Drug-induced hypertriglyceridemia with and without pancreatitis

Southern Medical Journal

Volumn 92, Issue 9, 1999, Pages 912-914

  Keung, Yi Kong ^a,b   Rizk, Rafat ^a   Wu, Xiao Yan ^a   Cobos, Everado ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ASPARAGINASE; TRIACYLGLYCEROL;

ACUTE PANCREATITIS; ADULT; ARTICLE; CASE REPORT; DRUG INDICATION; DRUG RESPONSE; ENZYME INHIBITION; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032883745     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199909000-00013     Document Type: Article

References (22)

1. Kirkwood JM, Strawderman MH, Ernstoff MS, et al: Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996; 14:7-17
2. Linker CA, Levitt LJ, O'Donnell M, et al: Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report. Blood 1991; 78:2814-2822
3. Olsen EA, Lichtenstein GR, Wilkinson WE: Changes in serum lipids in patients with condylomata acuminata treated with interferon alfa-n1 (Wellferon). J Am Acad Dermatol 1988; 19:286-289
4. Berruti A, Gorzegno G, Vitetta G, et al: Hypertriglyceridemia during long-term interferon-alpha therapy: efficacy of diet and gemfibrosil treatment. a case report. Tumori 1992; 78:353-355
5. Graessle D, Bonacini M, Chen S: Alpha-interferon and reversible hypertriglyceridemia. Ann Intern Med 1993; 118:316-317
6. Yamagishi S, Abe T, Sawada T: Human recombinant interferon alpha-2a (r IFN alpha-2a) therapy suppresses hepatic triglyceride lipase, leading to severe hypertriglyceridemia in a diabetic patient. Am J Gastroenterol 1994; 89:2280
7. Shinohara E, Yamashita S, Kihara S, et al: Interferon alpha induces disorder of lipid metabolism by lowering postheparin lipases and cholesteryl ester transfer protein activities in patients with chronic hepatitis C. Hepatology 1997; 25:1502-1506
8. Kurzrock R, Rohde MF, Quesada JR, et al: Recombinant gamma interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients. J Exp Med 1986; 164:1093-1101
9. Penarrubia MJ, Steegmann JL, Lavilla E, et al: Hypertriglyceridemia may be severe in CML patients treated with interferon-alpha. Am J Hematol 1995; 49:240-241
10. Sgarabotto D, Vianello F, Stefani PM, et al: Hypertriglyceridemia during long-term interferon-alpha therapy in a series of hematologic patients. J Interferon Cytokine Res 1997; 17:241-244
11. Oettgen HF, Stephenson PA, Schwartz MK, et al: Toxicity of E. coli L-asparaginase in man. Cancer 1970; 25:253-278
12. Parsons SK, Skapek SX, Neufeld EJ, et al: Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood 1997; 89:1886-1895
13. Steinherz PG: Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase. Cancer 1994; 74:3234-3239
14. Hoogerbrugge N, Jansen H, Hoogerbrugge PM: Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activity. Leukemia 1997; 11:1377-1379
15. Tozuka M, Yamauchi K, Hidaka H, et al: Characterization of hypertrilyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma. Ann Clin Lab Sci 1997; 27:351-357
16. Cremer P, Lakomek M, Beck W, et al: The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemia. Eur J Pediatr 1988; 147:64-67
17. Weetman RM, Baehner RL: Latent onset of clinical pancreatitis in children receiving L-asparaginase therapy. Cancer 1974; 34:780-785
18. Land VJ, Sutow WW, Fernbach DJ, et al: Toxicity of L-asparaginase in children with advanced leukemia. Cancer 1972; 30:339-347
19. McLean R, Martin S, Lam-Po-Tang PR: Fatal case of L-asparaginase induced pancreatitis. Lancet 1982; 2:1401-1402
20. Sharma P, Lim S, James D, et al. Pancreatitis may occur with a normal amylase concentration in hypertriglyceridemia. BMJ 1996; 313:1265
21. Garrington T, Bensard D, Ingram JD, et al: Successful management with octreotide of a child with L-asparaginase induced hemorrhagic pancreatitis. Med Pediatr Oncol 1998; 30:106-109
22. Cheung YF, Lee CW, Chan CF, et al: Somatostatin therapy in L-asparaginase-induced pancreatitis. Med Pediatr Oncol 1994; 22:421-424